Response

See Attachment

NR week 3 Reply to Peer 2

Institutional Review Boards (IRBs) assess the ethics and safety of research studies involving human subjects, such as behavioral studies or clinical trials for new drugs or medical devices. Health and Human Services oversees about 2,300 U.S.-based IRBs through routine or for-cause inspections to assess if they are following federal laws when reviewing research. But few IRBs are inspected. For example, one HHS agency aims to do just 3-4 routine inspections each year. Also, HHS agencies haven’t examined how many inspections are needed or if inspections could be changed to further reduce risks to human subjects (2023). More than 130 countries and international organizations have developed independent committees to approve or deny research that involves human subjects (Capili & Anastasi, 2024).

For many researchers conducting successful research is the most rewarding thing to do. But what happens when the research does not meet the IRB standards due to being biased, the truth is that many researchers find themselves facing such issues which are easy to occur when proposing a research theory. There are many things that can impact and affect the research, one can be the limited amount of information on the chosen topic, methodology and sample size. Often waiting for the review and approval from the IRB can be challenging. Four challenges identified (1) Community partners not being recognized as research partners (2) Cultural competence, language of consent forms, and literacy level of partners; (3) IRBs apply formulaic approaches to CEnR; & (4) Extensive delays in IRB preparation and approval potentially stifle the relationships with community partners (Onakomaiya et al, 2023).

In conclusion, getting research published and approved by the IRB is a tedious procedure. It requires understanding and knowledge of possible setbacks that can occur in the process of achieving the sought-out research. While these inefficiencies are an inevitable part of the research process, understanding common pitfalls can limit those hindrances (Shaffer & Huecker, 2025). Recommendations included (1) Training IRBs to understand CEnR principles to streamline and increase the flexibility of the IRB review process; (2) Identifying influential community stakeholders who can provide support for the study; and (3) Disseminating human subjects research training that is accessible to all community investigators to satisfy IRB concerns. The IRBs can benefit from more training in CEnR requirements and methodologies (Onakomaiya et al, 2023).

References

(2023, January 17). Institutional Review Boards: Actions Needed to Improve Federal Oversight and Examine Effectiveness. U.S. Government Accountability Office. https://www.gao.gov/products/gao-23-104721

Capili, B., & Anastasi, J. K. (2024). Ethical Research and the Institutional Review Board: An Introduction. The American journal of nursing, 124(3), 50–54. https://doi.org/10.1097/01.NAJ.0001008420.28033.e8

Onakomaiya, D., Pan, J., Roberts, T., Tan, H., Nadkarni, S., Godina, M., Park, J., Fraser, M., Kwon, S. C., Schoenthaler, A., & Islam, N. (2023). Challenges and recommendations to improve institutional review boards’ review of community-engaged research proposals: A scoping review. Journal of clinical and translational science, 7(1), e93. https://doi.org/10.1017/cts.2023.516

Shreffler J, Huecker MR. Common Pitfalls In the Research Process. [Updated 2023 Mar 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK568780/

NR week 3 Reply to Peer 1

The Need for Institutional Review Boards (IRBs) and Their Impact on Research Studies

     Institutional Review Boards (IRBs) play a vital role in the modern research landscape, particularly in healthcare settings where studies involve human participants. These ethics committees serve as essential gatekeepers, ensuring that research maintains high ethical standards while protecting participants from potential harm. My clinical experience working alongside nurse researchers has shown me firsthand how crucial these oversight bodies are to maintaining public trust in the research enterprise. The primary function of IRBs stems from historical ethical failures in research. The infamous Tuskegee Syphilis Study, where researchers withheld treatment from African American men with syphilis without their knowledge, and the horrific Nazi medical experiments during World War II demonstrated the dire consequences of unchecked research. These events led to the development of ethical frameworks like the Nuremberg Code and the Declaration of Helsinki, which eventually evolved into our current IRB system ‌(Barrow et al., 2022). Today, IRBs ensure that researchers obtain proper informed consent, maintain participant privacy, minimize risks, and equitably distribute research benefits.

      IRBs can significantly impact research studies in various ways. One example involves modifying participant recruitment methods. In a study by White et al. (2021), researchers examining pregnancy and birth experiences initially proposed recruiting vulnerable postpartum women through direct solicitation in hospital settings. The IRB identified potential constraint issues and required revisions to the recruitment protocol, mandating that initial contact occur through healthcare providers who had no stake in the research. This modification protected vulnerable participants from feeling pressured to participate but extended the recruitment timeline by several months. Another example of IRB impact relates to risk mitigation strategies. Stokes et al. (2017) conducted a study examining trauma-informed nursing interventions for patients with severe mental illness. The original protocol included detailed questioning about traumatic experiences without adequate psychological support mechanisms. The IRB required substantial revisions, including the addition of on-site mental health professionals during interviews, development of distress protocols, and follow-up mental health resources. While these changes enhanced participant protection, they increased study costs and necessitated additional personnel training.

     IRBs can also shape data collection procedures to protect participant privacy. In my own clinical setting, I observed a nursing quality improvement project examining medication errors that initially proposed collecting identifiable information about staff members involved in errors. The IRB required removing all staff data and implementing stronger data security measures to prevent potential professional repercussions for staff. This modification protected participants but limited some analytical opportunities regarding individual-level factors contributing to errors. The structure and function of IRBs continue to evolve alongside emerging research methodologies and technologies. Modern IRBs must navigate complex issues like genetic data privacy, social media-based recruitment, and international collaborative research (Somia Abdul Same’e & Antony Sheela Anmary, 2024). While sometimes perceived as administrative hurdles, IRBs ultimately strengthen research quality and protect both participants and researchers by ensuring ethical compliance.

References

Barrow, J. M., Khandhar, P. B., & Brannan, G. D. (2022). Research Ethics. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459281/

Somia Abdul Same’e, & Antony Sheela Anmary. (2024). Navigating the Ethical Complexities. Advances in Information Quality and Management, 139–158. https://doi.org/10.4018/978-1-6684-8526-2.ch009

Stokes, Y., Jacob, J.-D., Gifford, W., Squires, J., & Vandyk, A. (2017). Exploring nurses’ knowledge and experiences related to trauma-informed care. Global Qualitative Nursing Research, 4(4). https://doi.org/10.1177/2333393617734510

‌

White, A., Grady, C., Little, M., Sullivan, K., Clark, K., Ngwu, M., & Lyerly, A. D. (2021). IRB Decision‐Making about Minimal Risk Research with Pregnant Participants. Ethics & Human Research, 43(5), 2–17. https://doi.org/10.1002/eahr.500100

pediatric primary care

You see a child whose family believes in natural therapy for illnesses (e.g., diet therapy, massage, heat treatments).

How will you incorporate the family’s beliefs into the treatment of a child with an acute upper respiratory infection? With leukemia?

peds clinical experience

  • Did you face any challenges, any success? If so, what were they?
  • Describe the assessment of a patient, detailing the signs and symptoms (S&S), assessment, plan of care, and at least 3 possible differential diagnosis with rationales.
  • Mention the health promotion intervention for this patient.
  • What did you learn from this week’s clinical experience that can beneficial for you as an advanced practice nurse?
  • Support your plan of care with the current peer-reviewed research guideline.

Epidemiologic Study Designs

I. Application?of?Course?Knowledge: Answer all questions/criteria with explanations and detail.

Explain why and how you could use the study results in your practice to make a difference in client outcomes. If you cannot use the results, why not?

MANUSCRIPT PART 4-5

PLEASE SEE THE ATTACHED DOCUMENT

I UPLOADED MANUSCRIPT FROM 1 TO 3.

YOU NOW MUST COMPLETE SECTION 4 AND 5 ACCORDING THE INFORMATION RELATED IN PART 1 TO 3 OF THE MANUSCRIPT ATTACHED.

ALSO IS ATTACHED RUBRIC ADN GUIDELINES NEEDED 

ALSO ATTACHED THE TEMPLATE FOR PART 4 AND 5 , NOTE ALL THE GUIDELINES NEED AND APPENDICES. 

PLEASE STRICTLY FOLLOW INSTRUCTIONS, RUBRICS, GUIDELINES AND ALL THE INFORMATION PROVIDED, THIS ASSIGNMENT IS REALLY IMPORTANT FOR PASS MY CLASS

DUE DATE MARCH 24, 2025

2 PAGES

NO MORE THAN 10% PLAGIARISM ALLOWED

BETSY- SOAP 2

TOPIC: HYPERTENSION

YOU MUST COMPLETE EACH SECTION ON THE TEMPLATE WITH ENTIRE SENTENCES

CANT BE MISSED ANY SECTION PLEASE

REFERENCE NO OLDER THAN 5 YEARS ACCEPTED

DUE DATE MARCH 23,2025

DO YOUR BEST TO ASSIGN MORE LIKE THIS ONE

NO MORE THAN 10 % OF PLAGIARISM OR STUDENT PAPER ACCEPTED, WILL BE SUBMITTED BY TURNIN IN

HEALTH PROPOSAL PART 1

TOPIC: LUNG CANCER

LOCATION: UNITED STATES 

For this assignment you will submit Part One of your proposal, detailing a health problem that is

prevalent within your selected group and demonstrating your research of health promotion strategies for addressing this specific health problem ( LUNG CANCER). 

Directions:

1. Introduction. Describe the health problem. Don’t type “Introduction”.  (1 paragraph at least).

Using data and statistics, support your claim that the issue you selected is a problem.

What specifically will you address in your proposed health promotion program?

Be sure your proposed outcome is realistic and measurable.

2. Describe the vulnerable population.  (1-3 paragraphs).

What are the risk factors that make this a vulnerable population?

Use evidence to support the risk factors you have identified.

3. Provide a review of literature from scholarly journals (at least 2) of evidence-based interventions that address the problem. (2 paragraphs, one for each article).

After completing a literature search related to effective interventions for your chosen health promotion activity, write a review that evaluates the strengths and weaknesses of all the sources you have found. (2-3 paragraphs).

4. Select and present an appropriate health promotion/disease prevention theoretical or conceptual model that best serves as the guiding framework for the proposal.  (2-3 paragraphs).

For this assignment, a conclusion paragraph is not required.

Writing Assignment Requirements

Three  pages in length (excluding title page, references, and APPENDICES)

Follow APA format

Cite a minimum of five research articles- 6 references in total.

Please review the rubric prior to submission.

NO PLAGIO MORE THAN 10% CAN BE ALLOWED IN THIS ASSIGNMENT

DUE DATE MARCH 24, 2025

STRICTLY FOLLOW INSTRUCTIONS THIS ASSIGNMENT IS 40% OF CLASS